A Nanoplasmonic Portable Molecular Interaction Platform for High‐Throughput Drug Screening
Source abstract
Abstract
Abstract A fast and reliable method for the detection of molecular interactions in real‐time is necessary for drug screening and control of infections or diseases. Therefore, this study aims to develop a high‐throughput portable nanoplasmonic platform. This is done by integrating a nanocup array‐enhanced surface plasmon resonance (NanoSPR) sensor with a standard 96‐well plate or a simple eight‐pillar device, which can offer rapid and label‐free interaction analysis and highly sensitive binding kinetics for drug screening. To fabricate the wafer‐level NanoSPR biosensor, nanoimprint lithography, electron beam evaporation, and bonding technology have been used to offer low‐cost production on a mass scale. Meanwhile, a variety of ready‐to‐use NanoSPR biosensors are separately modified to demonstrate the high‐quality binding kinetics and affinity of different biomolecular interactions. Owing to their unique optical properties, the two developed portable NanoSPR devices provide the possibility of having a portable benchtop molecular interaction instrument that is very promising for meeting the needs of personal and laboratory testing. This study may pave the way for NanoSPR biosensors to achieve high‐throughput and easy‐to‐use molecular interaction analysis with outstanding performance.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Plasmonic and Surface Plasmon Research · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Life Science and Technology Huazhong University of Science and Technology 1037 Luo Yu Road Wuhan 430074 P. R. China
Liangzhun (Shanghai) Industrial Co. Ltd. 1582 Gu Mei Road Shanghai 200233 P. R. China
College of Life Science and Technology Wuhan University of Bioengineering 1 Hench Road Wuhan 430400 P. R. China
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities
References (45)
Show source-provided references
1. 10.1002/jmr.66010.1002/jmr.660 ↗
2. 10.1016/j.cis.2021.10243110.1016/j.cis.2021.102431 ↗
3. 10.1111/j.1742-4658.2010.07626.x10.1111/j.1742-4658.2010.07626.x ↗
4. 10.3390/bios1106018010.3390/bios11060180 ↗
5. Safari‐Alighiarloo N. · Gastroenterol. Hepatol. Bed Bench · 2014 · 7 · 17
6. 10.1016/S1367-5931(00)00251-910.1016/S1367-5931(00)00251-9 ↗
7. 10.1021/nn300415x10.1021/nn300415x ↗
8. 10.1016/0002-9610(78)90128-910.1016/0002-9610(78)90128-9 ↗
9. 10.1016/j.drudis.2017.02.00210.1016/j.drudis.2017.02.002 ↗
10. 10.1093/cvr/17.6.34410.1093/cvr/17.6.344 ↗
11. 10.1093/bioinformatics/btab15410.1093/bioinformatics/btab154 ↗
12. 10.1038/s41589-018-0008-510.1038/s41589-018-0008-5 ↗
13. 10.2174/13862070978910491510.2174/138620709789104915 ↗
14. Rhea K. · 2022 · 35510.1007/978-1-0716-1689-5_19 ↗
15. Yang D. · Analytical · 2016 · 508 · 78
16. 10.1007/978-1-0716-1166-1_510.1007/978-1-0716-1166-1_5 ↗
17. 10.1002/adfm.20110252510.1002/adfm.201102525 ↗
18. 10.1002/adfm.20100117710.1002/adfm.201001177 ↗
19. 10.1186/s13048-021-00872-310.1186/s13048-021-00872-3 ↗
20. 10.1021/nn501962y10.1021/nn501962y ↗
21. 10.1021/cr068107d10.1021/cr068107d ↗
22. 10.1002/mabi.20110043510.1002/mabi.201100435 ↗
23. 10.1016/j.bios.2020.11268510.1016/j.bios.2020.112685 ↗
24. 10.1016/j.bios.2019.11149410.1016/j.bios.2019.111494 ↗
25. Bohren C. F. · 2008
26. 10.3390/s2116526210.3390/s21165262 ↗
27. 10.1016/j.solmat.2014.07.03710.1016/j.solmat.2014.07.037 ↗
28. 10.1364/AO.19.00059110.1364/AO.19.000591 ↗
29. 10.1016/j.jenvman.2020.11191810.1016/j.jenvman.2020.111918 ↗
30. 10.1093/clinchem/hvab14810.1093/clinchem/hvab148 ↗
31. Goodrich J. · 2007
32. 10.1002/bmb.2044210.1002/bmb.20442 ↗
33. 10.1016/j.xcrm.2021.10031110.1016/j.xcrm.2021.100311 ↗
34. 10.1016/j.biotechadv.2021.10781710.1016/j.biotechadv.2021.107817 ↗
35. 10.1155/2016/820685410.1155/2016/8206854 ↗
36. Tan X. · bioRxiv · 2020
37. 10.1099/vir.0.2008/001891-010.1099/vir.0.2008/001891-0 ↗
38. 10.3390/v1304062810.3390/v13040628 ↗
39. 10.1016/S0956-5663(96)00074-710.1016/S0956-5663(96)00074-7 ↗
40. 10.1126/science.abb276210.1126/science.abb2762 ↗
41. 10.1016/j.ejca.2008.09.01310.1016/j.ejca.2008.09.013 ↗
42. S.Shak presented atSemin. Oncol.1999 26 71.
43. 10.1016/j.jve.2021.10005410.1016/j.jve.2021.100054 ↗
44. Y.Jia G.Shen S.Nguyen Y.Zhang K.‐S.Huang H.‐Y.Ho W.‐S.Hor C.‐H.Yang J. B.Bruning C.Li BioRxiv2021 2020.4.09.034942.
45. 10.1016/j.bios.2007.03.00310.1016/j.bios.2007.03.003 ↗